Quantum-Si to Participate in Upcoming Investment Conferences

BRANFORD, Conn.--(BUSINESS WIRE)-- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it will be participating in two upcoming investment conferences.

Jeff Hawkins, Quantum-Si's Chief Executive Officer, will participate in a fireside chat discussion at the UBS Global Healthcare Conference on Wednesday, November 13th, at 8:45 AM PT.

On Thursday, November 21st at 8:00 AM ET, Mr. Hawkins will participate in a fireside chat discussion at the Canaccord Medtech, Diagnostics & Services Forum in New York City.

A live and archived webcast of the event will be available in the “Investors” section of the Quantum-Si website under Events & Presentations.

About Quantum-Si Incorporated

Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company’s Platinum® instrument enables Next-Generation Protein Sequencing™ that advances proteomic research, drug discovery, and diagnostics beyond what has been possible with existing proteomic tools. Learn more at quantum-si.com or follow us on LinkedIn or X.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241105331252/en/

Investor Contact
Doug Farrell, VP, Investor Relations
[email protected]

Media Contact
Katherine Atkinson, SVP of Commercial Marketing
[email protected]

Source: Quantum-Si Incorporated

You May Also Be Interested In

• Vista Gold Appoints Gavin Ferguson as Managing Director, Vista Gold Australia
• Ulta Beauty Appoints Brieane Olson to Its Board of Directors
• OmniAb Raises 2026 Financial Guidance